Aspartame, the artificial sweetener commonly found in diet sodas and sugar-free snacks, may do significant harm to a person’s cardiovascular system.

Sotagliflozin, a dual SGLTI and SGLT2 inhibitor, can significantly reduce the risk of adverse cardiovascular events in patients with type 2 diabetes, CKD and additional cardiovascular risk factors, according to a new study of more than 10,000 patients. 

Military veterans face an increased risk of cardiovascular disease, making it especially important to ensure they receive high-quality care.

These findings show that opportunistic imaging could go a long way toward making more patients aware of the cardiovascular risks they face—all without requiring additional scans to be performed. 

Cardiologists have warned for years that healthy adults with no family history of CVD should not be taking low-dose aspirin every day—but as the saying goes, old habits die hard. 

Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.

The new blood test from Roche Diagnostics measures Lp(a) in terms of nanomoles per liter (nmol/L) as opposed to milligrams per deciliter (mg/dL).

Systole Health is focused on providing personalized healthcare to women with heart disease. “As a cardiologist, I have witnessed firsthand the struggles women face in managing their heart health," the company's co-founder said.